Blue Trust Inc. Buys 1,495 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Blue Trust Inc. boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 54.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,262 shares of the company’s stock after buying an additional 1,495 shares during the period. Blue Trust Inc.’s holdings in Bath & Body Works were worth $136,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in BBWI. First Community Trust NA acquired a new stake in shares of Bath & Body Works during the 2nd quarter worth approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after buying an additional 900 shares in the last quarter. EntryPoint Capital LLC boosted its stake in Bath & Body Works by 224.0% in the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after purchasing an additional 1,017 shares in the last quarter. GAMMA Investing LLC boosted its stake in Bath & Body Works by 65.4% in the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock worth $72,000 after purchasing an additional 730 shares in the last quarter. Finally, Tobam acquired a new position in Bath & Body Works in the second quarter worth $114,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Up 1.4 %

Shares of BBWI opened at $30.38 on Monday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The firm has a 50 day moving average of $30.71 and a 200 day moving average of $37.89. The company has a market capitalization of $6.78 billion, a P/E ratio of 7.83, a price-to-earnings-growth ratio of 0.95 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.63%. The ex-dividend date of this dividend was Friday, August 23rd. Bath & Body Works’s payout ratio is 20.62%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. Citigroup reduced their price objective on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research report on Tuesday, August 20th. Telsey Advisory Group restated an “outperform” rating and issued a $42.00 price objective on shares of Bath & Body Works in a research note on Thursday, September 26th. UBS Group lowered their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Finally, Bank of America reduced their target price on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $43.13.

Insider Buying and Selling at Bath & Body Works

In other news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was bought at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.27% of the stock is owned by insiders.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.